Bifunctional Role of Monocyte Subsets in Modulating Radiotherapy Combined Intra-Tumor αCD40 Agonist Induced Abscopal Effect

被引：0
|
作者：
Lan, W. [1 ,2 ]
Yao, J. [1 ,2 ]
Cao, M. [1 ,2 ,3 ]
Wang, Z. [1 ,2 ]
Xiang, B. [1 ,2 ]
Zhou, J. [1 ,2 ]
Liao, W. [1 ,2 ]
Liu, X. [1 ,2 ]
Yang, M. [1 ,2 ]
Zhang, S. [1 ,2 ]
Zhao, Y. [1 ,2 ]
机构：
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Chengdu, Peoples R China
[2] Univ Elect Sci & Technol China, Canc Hosp, Chengdu, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1046
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 13 条
  • [1] The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
    Frankish, Jamie
    Mukherjee, Debayan
    Romano, Erminia
    Billian-Frey, Katharina
    Schroder, Matthias
    Heinonen, Karl
    Merz, Christian
    Redondo Mueller, Mauricio
    Gieffers, Christian
    Hill, Oliver
    Thiemann, Meinolf
    Honeychurch, Jamie
    Illidge, Tim
    Sykora, Jaromir
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] AJ17 potentiates agonist CD40 antibody efficacy and attenuates agonist CD40 induced PD-L1 expression and associated toxicity in murine tumor models
    Gaur, Vidit
    Barnwal, Anjali
    Ateeq, Bushra
    Bhattacharyya, Jayanta
    CANCER RESEARCH, 2023, 83 (07)
  • [3] The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction
    Pinzon-Charry, A
    Schmidt, CW
    López, JA
    BREAST CANCER RESEARCH, 2006, 8 (01)
  • [4] The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction
    Alberto Pinzon-Charry
    Chris W Schmidt
    José Alejandro López
    Breast Cancer Research, 8
  • [5] Radiation Combined With CD40 Agonist And PD-1 Blockade Enhances B-cell Tumor Infiltration And Local Tumor Control
    Sumner, W.
    Kim, S.
    Miyauchi, S.
    Sanders, P. D.
    Mell, L. K.
    Cohen, E.
    Gutkind, J. S.
    Califano, J. A.
    Sharabi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E565 - E565
  • [6] RADIOTHERAPY AND CTLA-4 BLOCKADE EXPAND ANTITUMOR T CELLS DIFFERENTIATION STATES AND COOPERATE WITH CD40 AGONIST TO INDUCE TUMOR REJECTION
    Rudqvist, Nils
    Lhuillier, Claire
    Charpentier, Maud
    Wennerberg, Erik
    Spada, Sheila
    Sheridan, Caroline
    Zhou, Xi Kathy
    Zhang, Tuo
    Sims, Jennifer
    Alonso, Alicia
    Demaria, Sandra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A283 - A284
  • [7] Synergistic Effects of CD40 Agonist Antibody and DC-Derived Exosomes Enhance Anti-Tumor Efficacy by Modulating the Tumor Microenvironment and Reducing Metastasis in a Murine Melanoma Model
    Gaur, Vidit
    Bhattacharyya, Jayanta
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [8] Agonist CD40 engineered smart immunosomes induced anti-tumor immunity, reduced associated toxicities and showed tumor free survival in murine glioblastoma model
    Gaur, Vidit
    Tyagi, Witty
    Das, Sanjeev
    Ganguly, Surajit
    Bhattacharyya, Jayanta
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Critical role of tumor necrosis factor-α and NF-κB in interferon-γ-induced CD40 expression in microglia/macrophages
    Nguyen, VT
    Benveniste, EN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 13796 - 13803
  • [10] Nifedipine inhibits tumor necrosis factor-α-induced upregulation of monocyte chemoattractant protein-1 mRNA levels by suppressing CD40 expression in endothelial cells
    Yamagishi, S
    Takeuchi, M
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2005, 31 (01) : 13 - 17
12